MARKET

AKYA

AKYA

Akoya Biosciences, Inc.
NASDAQ
2.460
+0.020
+0.82%
After Hours: 2.460 0 0.00% 16:01 07/26 EDT
OPEN
2.500
PREV CLOSE
2.440
HIGH
2.500
LOW
2.430
VOLUME
104.41K
TURNOVER
0
52 WEEK HIGH
7.55
52 WEEK LOW
1.880
MARKET CAP
121.49M
P/E (TTM)
-1.6730
1D
5D
1M
3M
1Y
5Y
1D
U.S. RESEARCH ROUNDUP-Colgate-Palmolive, McKesson, Microsoft
Wall Street analysts revise their ratings and price targets on several U.S.-listed companies. Colgate-Palmolive, McKesson, Microsoft and Air Products & Chemicals among those. AIG, AIG and others have seen their target prices cut by some analysts.
Reuters · 3d ago
AKOYA BIOSCIENCES INC <AKYA.O>: STEPHENS CUTS TARGET PRICE TO $4.50 FROM $6
Reuters · 3d ago
Weekly Report: what happened at AKYA last week (0715-0719)?
Weekly Report · 4d ago
Akoya Biosciences: Poised for Recovery and Growth Amidst Market Challenges
TipRanks · 07/17 16:26
Weekly Report: what happened at AKYA last week (0708-0712)?
Weekly Report · 07/15 09:00
Weekly Report: what happened at AKYA last week (0701-0705)?
Weekly Report · 07/08 09:00
Weekly Report: what happened at AKYA last week (0624-0628)?
Weekly Report · 07/01 09:01
Market Might Still Lack Some Conviction On Akoya Biosciences, Inc. (NASDAQ:AKYA) Even After 31% Share Price Boost
Akoya Biosciences, Inc. Share price has bounced 31% in the last month. The company's price-to-sales ratio of 1.4x is lower than most other companies in the Life Sciences industry. Its forecasted revenue growth is higher than the rest of its industry. However, the company's P/S might be low for a reason.
Simply Wall St · 06/27 10:18
More
About AKYA
Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery, clinical research, and diagnostics. It offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. It offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode Panels and PhenoCycler, PhenoImager Fusion and PhenoImager HT Instruments. Its PhenoCycler platform provides ultra-high parameter biomarker discovery, with the ability to analyze high-plex single-cell resolution across the entire tissue sample. Its PhenoImager platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded (FFPE) tissue sections, and tissue microarrays (TMAs).

Webull offers Akoya Biosciences Inc stock information, including NASDAQ: AKYA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AKYA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AKYA stock methods without spending real money on the virtual paper trading platform.